Health news
The Food and Drug Administration (FDA) has cleared Smith+Nephew’s PICO 7 and PICO 14 Single Use Negative Pressure Wound Therapy (sNPWT) Systems for use on closed surgical incisions to aid in reducing the incidence of…
The Food and Drug Administration (FDA) has expanded the approval of Veklury® (remdesivir; Gilead Sciences) to include treatment of COVID-19 in nonhospitalized patients aged 12 years and older (weighing at least 40kg) with mild to…
Local injection site reactions (LIR) are the most commonly occurring cutaneous manifestations after COVID-19 vaccination and most of the reactions occur after the first dose, investigators reported in a study published in the Journal of…
Gilead Sciences has announced the removal of counterfeit and tampered Gilead-labeled HIV medications, including bottles labeled as Biktarvy® (bictegravir, emtricitabine, tenofovir alafenamide) and Descovy® (emtricitabine and tenofovir alafenamide), from the US supply chain. Biktarvy is…
The safety and efficacy of a shorter 5-day course of antibiotics were found to be comparable to a standard 10-day course in children with uncomplicated community-acquired pneumonia (CAP), according to the findings of a clinical…
Influenza vaccination reduces the risk of serious illness in children even when the circulating virus is antigenically different from the vaccine virus, according to a Centers for Disease Control and Prevention (CDC) study published in…
Health care providers should stop using the LuSys Laboratories COVID-19 Antigen Test (Nasal/Saliva) and the LuSys Laboratories COVID-19 IgG/IgM Antibody Test as the performance of these tests has not been adequately established, according to the…
The Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to 2 oral antiviral therapies for COVID-19. Concise drug information for molnupiravir and Paxlovid is provided below. Prior to initiating treatment, careful consideration…
The Food and Drug Administration (FDA) has granted Fast Track designation to BPZE1 for active booster immunization against pertussis. BPZE1 is an investigational live-attenuated intranasal vaccine designed to induce comprehensive and durable protection against Bordetella…
The Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for Paxlovid (nirmatrelvir tablets co-packaged with ritonavir tablets for oral use) for the treatment of mild to moderate COVID-19 in patients 12…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021